Xenodiagnosis to Detect Borrelia burgdorferi Infection: A First-in-Human Study

Background. Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector (Ixodes scapularis). No convincing evidence exists for the persistence of viable sp...

Full description

Saved in:
Bibliographic Details
Published inClinical infectious diseases Vol. 58; no. 7; pp. 937 - 945
Main Authors Marques, Adriana, Telford, Sam R., Turk, Siu-Ping, Chung, Erin, Williams, Carla, Dardick, Kenneth, Krause, Peter J., Brandeburg, Christina, Crowder, Christopher D., Carolan, Heather E., Eshoo, Mark W., Shaw, Pamela A., Hu, Linden T.
Format Journal Article
LanguageEnglish
Published Oxford OXFORD UNIVERSITY PRESS 01.04.2014
Oxford University Press
Subjects
Online AccessGet full text
ISSN1058-4838
1537-6591
1537-6591
DOI10.1093/cid/cit939

Cover

Loading…
Abstract Background. Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector (Ixodes scapularis). No convincing evidence exists for the persistence of viable spirochetes after recommended courses of antibiotic therapy in humans. We determined the safety of using I. scapularis larvae for the xenodiagnosis of B. burgdorferi infection in humans. Methods. Laboratory-reared larval I. scapularis ticks were placed on 36 subjects and allowed to feed to repletion. Ticks were tested for B. burgdorferi by polymerase chain reaction (PCR), culture, and/or isothermal amplification followed by PCR and electrospray ionization mass spectroscopy. In addition, attempts were made to infect immunodeficient mice by tick bite or inoculation of tick contents. Xenodiagnosis was repeated in 7 individuals. Results. Xenodiagnosis was well tolerated with no severe adverse events. The most common adverse event was mild itching at the tick attachment site. Xenodiagnosis was negative in 16 patients with posttreatment Lyme disease syndrome (PTLDS) and/or high C6 antibody levels and in 5 patients after completing antibiotic therapy for erythema migrans. Xenodiagnosis was positive for B. burgdorferi DNA in a patient with erythema migrans early during therapy and in a patient with PTLDS. There is insufficient evidence, however, to conclude that viable spirochetes were present in either patient. Conclusions. Xenodiagnosis using Ixodes scapularis larvae was safe and well tolerated. Further studies are needed to determine the sensitivity of xenodiagnosis in patients with Lyme disease and the significance of a positive result. Clinical Trials Registration. NCT01143558.
AbstractList Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector (Ixodes scapularis). No convincing evidence exists for the persistence of viable spirochetes after recommended courses of antibiotic therapy in humans. We determined the safety of using I. scapularis larvae for the xenodiagnosis of B. burgdorferi infection in humans.BACKGROUNDAnimal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector (Ixodes scapularis). No convincing evidence exists for the persistence of viable spirochetes after recommended courses of antibiotic therapy in humans. We determined the safety of using I. scapularis larvae for the xenodiagnosis of B. burgdorferi infection in humans.Laboratory-reared larval I. scapularis ticks were placed on 36 subjects and allowed to feed to repletion. Ticks were tested for B. burgdorferi by polymerase chain reaction (PCR), culture, and/or isothermal amplification followed by PCR and electrospray ionization mass spectroscopy. In addition, attempts were made to infect immunodeficient mice by tick bite or inoculation of tick contents. Xenodiagnosis was repeated in 7 individuals.METHODSLaboratory-reared larval I. scapularis ticks were placed on 36 subjects and allowed to feed to repletion. Ticks were tested for B. burgdorferi by polymerase chain reaction (PCR), culture, and/or isothermal amplification followed by PCR and electrospray ionization mass spectroscopy. In addition, attempts were made to infect immunodeficient mice by tick bite or inoculation of tick contents. Xenodiagnosis was repeated in 7 individuals.Xenodiagnosis was well tolerated with no severe adverse events. The most common adverse event was mild itching at the tick attachment site. Xenodiagnosis was negative in 16 patients with posttreatment Lyme disease syndrome (PTLDS) and/or high C6 antibody levels and in 5 patients after completing antibiotic therapy for erythema migrans. Xenodiagnosis was positive for B. burgdorferi DNA in a patient with erythema migrans early during therapy and in a patient with PTLDS. There is insufficient evidence, however, to conclude that viable spirochetes were present in either patient.RESULTSXenodiagnosis was well tolerated with no severe adverse events. The most common adverse event was mild itching at the tick attachment site. Xenodiagnosis was negative in 16 patients with posttreatment Lyme disease syndrome (PTLDS) and/or high C6 antibody levels and in 5 patients after completing antibiotic therapy for erythema migrans. Xenodiagnosis was positive for B. burgdorferi DNA in a patient with erythema migrans early during therapy and in a patient with PTLDS. There is insufficient evidence, however, to conclude that viable spirochetes were present in either patient.Xenodiagnosis using Ixodes scapularis larvae was safe and well tolerated. Further studies are needed to determine the sensitivity of xenodiagnosis in patients with Lyme disease and the significance of a positive result. Clinical Trials Registration NCT01143558.CONCLUSIONSXenodiagnosis using Ixodes scapularis larvae was safe and well tolerated. Further studies are needed to determine the sensitivity of xenodiagnosis in patients with Lyme disease and the significance of a positive result. Clinical Trials Registration NCT01143558.
Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector (Ixodes scapularis). No convincing evidence exists for the persistence of viable spirochetes after recommended courses of antibiotic therapy in humans. We determined the safety of using I. scapularis larvae for the xenodiagnosis of B. burgdorferi infection in humans. Laboratory-reared larval I. scapularis ticks were placed on 36 subjects and allowed to feed to repletion. Ticks were tested for B. burgdorferi by polymerase chain reaction (PCR), culture, and/or isothermal amplification followed by PCR and electrospray ionization mass spectroscopy. In addition, attempts were made to infect immunodeficient mice by tick bite or inoculation of tick contents. Xenodiagnosis was repeated in 7 individuals. Xenodiagnosis was well tolerated with no severe adverse events. The most common adverse event was mild itching at the tick attachment site. Xenodiagnosis was negative in 16 patients with posttreatment Lyme disease syndrome (PTLDS) and/or high C6 antibody levels and in 5 patients after completing antibiotic therapy for erythema migrans. Xenodiagnosis was positive for B. burgdorferi DNA in a patient with erythema migrans early during therapy and in a patient with PTLDS. There is insufficient evidence, however, to conclude that viable spirochetes were present in either patient. Xenodiagnosis using Ixodes scapularis larvae was safe and well tolerated. Further studies are needed to determine the sensitivity of xenodiagnosis in patients with Lyme disease and the significance of a positive result. Clinical Trials Registration NCT01143558.
Background. Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector (Ixodes scapularis). No convincing evidence exists for the persistence of viable spirochetes after recommended courses of antibiotic therapy in humans. We determined the safety of using I. scapularis larvae for the xenodiagnosis of B. burgdorferi infection in humans. Methods. Laboratory-reared larval I. scapularis ticks were placed on 36 subjects and allowed to feed to repletion. Ticks were tested for B. burgdorferi by polymerase chain reaction (PCR), culture, and/or isothermal amplification followed by PCR and electrospray ionization mass spectroscopy. In addition, attempts were made to infect immunodeficient mice by tick bite or inoculation of tick contents. Xenodiagnosis was repeated in 7 individuals. Results. Xenodiagnosis was well tolerated with no severe adverse events. The most common adverse event was mild itching at the tick attachment site. Xenodiagnosis was negative in 16 patients with posttreatment Lyme disease syndrome (PTLDS) and/or high C6 antibody levels and in 5 patients after completing antibiotic therapy for erythema migrans. Xenodiagnosis was positive for B. burgdorferi DNA in a patient with erythema migrans early during therapy and in a patient with PTLDS. There is insufficient evidence, however, to conclude that viable spirochetes were present in either patient. Conclusions. Xenodiagnosis using Ixodes scapularis larvae was safe and well tolerated. Further studies are needed to determine the sensitivity of xenodiagnosis in patients with Lyme disease and the significance of a positive result. Clinical Trials Registration. NCT01143558.
Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector (Ixodes scapularis). No convincing evidence exists for the persistence of viable spirochetes after recommended courses of antibiotic therapy in humans. We determined the safety of using I. scapularis larvae for the xenodiagnosis of B. burgdorferi infection in humans. Laboratory-reared larval I. scapularis ticks were placed on 36 subjects and allowed to feed to repletion. Ticks were tested for B. burgdorferi by polymerase chain reaction (PCR), culture, and/or isothermal amplification followed by PCR and electrospray ionization mass spectroscopy. In addition, attempts were made to infect immunodeficient mice by tick bite or inoculation of tick contents. Xenodiagnosis was repeated in 7 individuals. Xenodiagnosis was well tolerated with no severe adverse events. The most common adverse event was mild itching at the tick attachment site. Xenodiagnosis was negative in 16 patients with posttreatment Lyme disease syndrome (PTLDS) and/or high C6 antibody levels and in 5 patients after completing antibiotic therapy for erythema migrans. Xenodiagnosis was positive for B. burgdorferi DNA in a patient with erythema migrans early during therapy and in a patient with PTLDS. There is insufficient evidence, however, to conclude that viable spirochetes were present in either patient. Xenodiagnosis using Ixodes scapularis larvae was safe and well tolerated. Further studies are needed to determine the sensitivity of xenodiagnosis in patients with Lyme disease and the significance of a positive result.
Xenodiagnosis using Ixodes scapularis larvae in humans is safe and well tolerated. There is no evidence of persistence of infection after antibiotic therapy in the majority of individuals. Background.  Animal studies suggest that Borrelia burgdorferi , the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means including xenodiagnosis using the natural tick vector ( Ixodes scapularis ). No convincing evidence exists for the persistence of viable spirochetes after recommended courses of antibiotic therapy in humans. We determined the safety of using I. scapularis larvae for the xenodiagnosis of B. burgdorferi infection in humans. Methods.  Laboratory-reared larval I. scapularis ticks were placed on 36 subjects and allowed to feed to repletion. Ticks were tested for B. burgdorferi by polymerase chain reaction (PCR), culture, and/or isothermal amplification followed by PCR and electrospray ionization mass spectroscopy. In addition, attempts were made to infect immunodeficient mice by tick bite or inoculation of tick contents. Xenodiagnosis was repeated in 7 individuals. Results.  Xenodiagnosis was well tolerated with no severe adverse events. The most common adverse event was mild itching at the tick attachment site. Xenodiagnosis was negative in 16 patients with posttreatment Lyme disease syndrome (PTLDS) and/or high C6 antibody levels and in 5 patients after completing antibiotic therapy for erythema migrans. Xenodiagnosis was positive for B. burgdorferi DNA in a patient with erythema migrans early during therapy and in a patient with PTLDS. There is insufficient evidence, however, to conclude that viable spirochetes were present in either patient. Conclusions.  Xenodiagnosis using Ixodes scapularis larvae was safe and well tolerated. Further studies are needed to determine the sensitivity of xenodiagnosis in patients with Lyme disease and the significance of a positive result. Clinical Trials Registration  NCT01143558.
Author Dardick, Kenneth
Krause, Peter J.
Carolan, Heather E.
Marques, Adriana
Telford, Sam R.
Eshoo, Mark W.
Turk, Siu-Ping
Brandeburg, Christina
Shaw, Pamela A.
Hu, Linden T.
Chung, Erin
Crowder, Christopher D.
Williams, Carla
AuthorAffiliation 2 Department of Infectious Disease and Global Health , Cummings School of Veterinary Medicine, Tufts University
6 Department of Epidemiology of Microbial Diseases , Yale School of Public Health, Yale School of Medicine, New Haven, Connecticut
1 Laboratory of Clinical Infectious Diseases , National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
3 Department of Medicine, Division of Geographic Medicine and Infectious Diseases , Tufts Medical Center, Boston, Massachusetts
5 Mansfield Family Practice, Storrs
7 Ibis Biosciences , Inc., a subsidiary of Abbott Company, Carlsbad, California
8 Biostatistics Research Branch , National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
4 SAIC-Frederick, Inc., NCI-Frederick , Maryland
AuthorAffiliation_xml – name: 3 Department of Medicine, Division of Geographic Medicine and Infectious Diseases , Tufts Medical Center, Boston, Massachusetts
– name: 6 Department of Epidemiology of Microbial Diseases , Yale School of Public Health, Yale School of Medicine, New Haven, Connecticut
– name: 7 Ibis Biosciences , Inc., a subsidiary of Abbott Company, Carlsbad, California
– name: 8 Biostatistics Research Branch , National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
– name: 4 SAIC-Frederick, Inc., NCI-Frederick , Maryland
– name: 2 Department of Infectious Disease and Global Health , Cummings School of Veterinary Medicine, Tufts University
– name: 1 Laboratory of Clinical Infectious Diseases , National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
– name: 5 Mansfield Family Practice, Storrs
Author_xml – sequence: 1
  givenname: Adriana
  surname: Marques
  fullname: Marques, Adriana
– sequence: 2
  givenname: Sam R.
  surname: Telford
  fullname: Telford, Sam R.
– sequence: 3
  givenname: Siu-Ping
  surname: Turk
  fullname: Turk, Siu-Ping
– sequence: 4
  givenname: Erin
  surname: Chung
  fullname: Chung, Erin
– sequence: 5
  givenname: Carla
  surname: Williams
  fullname: Williams, Carla
– sequence: 6
  givenname: Kenneth
  surname: Dardick
  fullname: Dardick, Kenneth
– sequence: 7
  givenname: Peter J.
  surname: Krause
  fullname: Krause, Peter J.
– sequence: 8
  givenname: Christina
  surname: Brandeburg
  fullname: Brandeburg, Christina
– sequence: 9
  givenname: Christopher D.
  surname: Crowder
  fullname: Crowder, Christopher D.
– sequence: 10
  givenname: Heather E.
  surname: Carolan
  fullname: Carolan, Heather E.
– sequence: 11
  givenname: Mark W.
  surname: Eshoo
  fullname: Eshoo, Mark W.
– sequence: 12
  givenname: Pamela A.
  surname: Shaw
  fullname: Shaw, Pamela A.
– sequence: 13
  givenname: Linden T.
  surname: Hu
  fullname: Hu, Linden T.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28351578$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/24523212$$D View this record in MEDLINE/PubMed
BookMark eNptkd1rFDEUxYNU7Ie--K4MSEGE0XuTySTxQajV2kLRBxV8C9lMZs0ym9QkU-h_b5Zday0-hATO7957bs4h2QsxOEKeIrxGUOyN9UM9RTH1gBwgZ6LtucK9-gYu204yuU8Oc14BIErgj8g-7ThlFOkB-fzDhTh4swwx-9yU2HxwxdnSvI8pucmbZjGn5RDT6JJvLsJYNR_D2-akOfMpl9aH9nxem9B8LfNw85g8HM2U3ZPdfUS-n338dnreXn75dHF6ctnajsvSLlzXO6CCAyhlLJfQmYGP2CngFns1IDLTSUQhRgeWgsDByoFKhG6EHtkRebftezUv1m6wLpRkJn2V_NqkGx2N1_8qwf_Uy3itmeK0B1YbvNw1SPHX7HLRa5-tmyYTXJyzRg5CKBRMVvTFPXQV5xTqepVCoEoJCpV6ftfRrZU_X12B4x1gsjXTmEywPv_lJOPIxWbcqy1nU8w5ufEWQdCbvHXNW2_zrjDcg6tgNgnVrf30_5Jn25JVLjHd8QkMe0HZb-IWtqM
CODEN CIDIEL
CitedBy_id crossref_primary_10_1016_j_idc_2015_02_012
crossref_primary_10_3390_microorganisms11092301
crossref_primary_10_3201_eid2906_221685
crossref_primary_10_3389_fmicb_2016_01744
crossref_primary_10_3390_antibiotics9090542
crossref_primary_10_1016_j_idc_2022_04_004
crossref_primary_10_1097_IM9_0000000000000115
crossref_primary_10_3389_fpubh_2021_819541
crossref_primary_10_1371_journal_pone_0189071
crossref_primary_10_3390_antibiotics8040269
crossref_primary_10_1128_cmr_00074_22
crossref_primary_10_1371_journal_pone_0225012
crossref_primary_10_3389_fmed_2023_1183344
crossref_primary_10_4236_wjns_2020_101001
crossref_primary_10_3390_ijms242316906
crossref_primary_10_3390_healthcare8030322
crossref_primary_10_3390_genes13091604
crossref_primary_10_1016_j_pt_2019_12_017
crossref_primary_10_1016_j_cmi_2024_10_014
crossref_primary_10_1093_pch_19_7_384
crossref_primary_10_1093_cid_cit942
crossref_primary_10_3389_fmicb_2016_00062
crossref_primary_10_1093_jme_tjv185
crossref_primary_10_1128_iai_00065_25
crossref_primary_10_3389_fneur_2021_628045
crossref_primary_10_1016_j_idc_2015_02_006
crossref_primary_10_1038_emi_2014_53
crossref_primary_10_1126_scitranslmed_ado2103
crossref_primary_10_3390_antibiotics7040089
crossref_primary_10_1177_2040622320922005
crossref_primary_10_1097_MOP_0000000000000167
crossref_primary_10_1016_j_ttbdis_2021_101782
crossref_primary_10_1080_10408363_2018_1450353
crossref_primary_10_1016_j_cmi_2015_11_009
crossref_primary_10_1016_j_crmicr_2020_05_003
crossref_primary_10_1016_j_epidem_2016_12_002
crossref_primary_10_3184_003685018X15360040523730
crossref_primary_10_1038_s41598_021_85624_5
crossref_primary_10_1371_journal_pone_0135828
crossref_primary_10_3389_fneur_2018_01048
crossref_primary_10_1093_infdis_jiaa719
crossref_primary_10_1111_jam_13523
crossref_primary_10_1128_IAI_00442_19
crossref_primary_10_3390_antibiotics6010010
crossref_primary_10_1093_jme_tjx250
crossref_primary_10_3389_fmed_2020_00006
crossref_primary_10_3389_fcimb_2020_00241
crossref_primary_10_1186_s12866_023_02935_5
crossref_primary_10_1007_s40471_016_0082_8
crossref_primary_10_1093_femsec_fix129
crossref_primary_10_3390_microbiolres15030088
crossref_primary_10_1097_NAN_0000000000000195
crossref_primary_10_1002_art_38756
crossref_primary_10_1111_1462_2920_13897
crossref_primary_10_1371_journal_pone_0117207
crossref_primary_10_3389_fmed_2017_00169
crossref_primary_10_3389_fmed_2021_666554
crossref_primary_10_3390_microorganisms11071759
crossref_primary_10_1038_nrneurol_2015_121
crossref_primary_10_1186_s12906_019_2450_7
crossref_primary_10_3389_fimmu_2024_1430419
crossref_primary_10_1128_AAC_00237_19
crossref_primary_10_1128_mbio_03440_21
crossref_primary_10_1586_14787210_2014_940900
crossref_primary_10_3238_arztebl_2018_0751
crossref_primary_10_1016_j_cmi_2019_06_033
crossref_primary_10_1038_s41598_020_59600_4
crossref_primary_10_3390_pathogens11050530
crossref_primary_10_1016_j_micinf_2017_06_002
crossref_primary_10_1016_j_pt_2015_03_008
crossref_primary_10_3390_antibiotics4030397
crossref_primary_10_1128_iai_00018_24
crossref_primary_10_1172_JCI138062
crossref_primary_10_1586_14787210_2014_966084
crossref_primary_10_3390_bios12100819
Cites_doi 10.1093/jmedent/47.1.89
10.1056/NEJM200107123450202
10.1603/ME12038
10.1212/01.WNL.0000284604.61160.2d
10.1172/JCI58813
10.1128/JCM.38.6.2191-2199.2000
10.1002/art.30384
10.1078/1438-4221-00285
10.1086/315340
10.1128/AAC.01050-07
10.1371/journal.pone.0036825
10.1056/NEJMra072023
10.1128/JCM.30.12.3082-3088.1992
10.1089/vbz.2012.1012
10.1128/AAC.00788-09
10.1086/345284
10.1371/journal.pone.0029914
10.1128/CMR.00004-09
10.1128/JCM.01669-09
10.1371/journal.pone.0010650
10.1212/01.WNL.0000071227.23769.9E
10.1086/382594
10.1086/508667
10.1128/JCM.27.8.1723-1727.1989
10.1086/432935
10.4269/ajtmh.1987.36.92
10.1586/eri.10.174
ContentType Journal Article
Copyright Copyright © 2014 Oxford University Press on behalf of the Infectious Diseases Society of America
2015 INIST-CNRS
Copyright Oxford University Press, UK Apr 1, 2014
Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US. 2014
Copyright_xml – notice: Copyright © 2014 Oxford University Press on behalf of the Infectious Diseases Society of America
– notice: 2015 INIST-CNRS
– notice: Copyright Oxford University Press, UK Apr 1, 2014
– notice: Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US. 2014
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T2
7T7
7U7
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
5PM
DOI 10.1093/cid/cit939
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Health and Safety Science Abstracts (Full archive)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Toxicology Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
Toxicology Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Safety Science Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Virology and AIDS Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1537-6591
EndPage 945
ExternalDocumentID PMC3952603
3256864721
24523212
28351578
10_1093_cid_cit939
24031672
Genre Research Support, N.I.H., Intramural
Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
Feature
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: 2R44AI077156
– fundername: Intramural NIH HHS
– fundername: NIAID NIH HHS
  grantid: R21AI082436
– fundername: NIAID NIH HHS
  grantid: R21 AI082436
– fundername: NIAID NIH HHS
  grantid: R44 AI077156
GroupedDBID ---
..I
.2P
.I3
.ZR
08P
0R~
1KJ
1TH
29B
2AX
2WC
36B
4.4
48X
53G
5GY
5RE
5VS
5WD
6J9
70D
AABZA
AACGO
AACZT
AAJKP
AAJQQ
AAMVS
AANCE
AAOGV
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
ABBHK
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPLY
ABPQP
ABPTD
ABQLI
ABQNK
ABTLG
ABVGC
ABWST
ABXSQ
ABXVV
ABZBJ
ACGFO
ACGFS
ACHIC
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADQXQ
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFZL
AFIYH
AFOFC
AFRAH
AFXAL
AGINJ
AGKEF
AGORE
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJBYB
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
AQKUS
AQVQM
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CDBKE
CS3
CZ4
DAKXR
DCCCD
DIK
DILTD
DU5
D~K
E3Z
EBS
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
H13
H5~
HAR
HW0
HZ~
IOX
IPSME
J21
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
JXSIZ
KAQDR
KBUDW
KOP
KSI
KSN
L7B
MHKGH
MJL
ML0
N9A
NGC
NOMLY
NOYVH
NU-
NVLIB
O9-
OAUYM
OAWHX
OCZFY
ODMLO
ODZKP
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
P6G
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TMA
TR2
W8F
X7H
YAYTL
YKOAZ
YXANX
~91
~S-
AAYXX
CITATION
.GJ
3O-
AAPGJ
AAWDT
AAYOK
ABNGD
ABSMQ
ACFRR
ACPQN
ACUKT
ACVCV
ACZBC
ADMTO
AEKPW
AFFNX
AFFQV
AFSHK
AFYAG
AGKRT
AGMDO
AI.
AJDVS
APJGH
AQDSO
ASPBG
AVNTJ
AVWKF
AZFZN
BZKNY
C1A
EIHJH
FEDTE
HQ3
HTVGU
HVGLF
IQODW
J5H
M49
MBLQV
N4W
O0~
OBFPC
O~Y
PB-
VH1
Y6R
ZGI
AGQPQ
AHGBF
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T2
7T7
7U7
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
5PM
ID FETCH-LOGICAL-c458t-be46e02750099ac5804ad5f14905c169d113a481177fe0c2071dc8d28104f0613
ISSN 1058-4838
1537-6591
IngestDate Thu Aug 21 18:07:57 EDT 2025
Fri Jul 11 15:34:41 EDT 2025
Mon Jun 30 07:16:46 EDT 2025
Mon Jul 21 05:50:56 EDT 2025
Wed Apr 02 07:24:41 EDT 2025
Tue Jul 01 04:19:53 EDT 2025
Thu Apr 24 23:11:15 EDT 2025
Fri Jun 20 01:32:54 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Infection
Human
Borrelia burgdorferi
Spirochaetaceae
Spirochaetales
Spirochaetosis
Borrelia infection
Bacteriosis
Bacteria
Lyme disease
xenodiagnosis
Ixodes scapularis
human
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c458t-be46e02750099ac5804ad5f14905c169d113a481177fe0c2071dc8d28104f0613
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-2
content type line 23
Presented in part: 2013 International Conference on Lyme Borreliosis and other Tick Borne Diseases, Boston, Massachusetts, 18–21 August 2013. Poster B040.
OpenAccessLink https://academic.oup.com/cid/article-pdf/58/7/937/17351643/cit939.pdf
PMID 24523212
PQID 1510299720
PQPubID 48300
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3952603
proquest_miscellaneous_1507791738
proquest_journals_1510299720
pubmed_primary_24523212
pascalfrancis_primary_28351578
crossref_primary_10_1093_cid_cit939
crossref_citationtrail_10_1093_cid_cit939
jstor_primary_24031672
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-04-01
PublicationDateYYYYMMDD 2014-04-01
PublicationDate_xml – month: 04
  year: 2014
  text: 2014-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: United States
PublicationTitle Clinical infectious diseases
PublicationTitleAlternate Clin Infect Dis
PublicationYear 2014
Publisher OXFORD UNIVERSITY PRESS
Oxford University Press
Publisher_xml – name: OXFORD UNIVERSITY PRESS
– name: Oxford University Press
References Eshoo ( key 20170522094913_CIT939C26) 2012; 7
Schwartz ( key 20170522094913_CIT939C29) 1992; 30
Sinsky ( key 20170522094913_CIT939C14) 1989; 27
Wormser ( key 20170522094913_CIT939C16) 2009; 22
Centers for Disease Control and Prevention ( key 20170522094913_CIT939C19)
Bockenstedt ( key 20170522094913_CIT939C28) 2012; 122
Straubinger ( key 20170522094913_CIT939C8) 2000; 181
Fallon ( key 20170522094913_CIT939C5) 2008; 70
Crowder ( key 20170522094913_CIT939C23) 2010; 47
Eshoo ( key 20170522094913_CIT939C27) 2010; 48
Bunikis ( key 20170522094913_CIT939C22) 2004; 189
Hua ( key 20170522094913_CIT939C15) 2003; 293
Feder ( key 20170522094913_CIT939C3) 2007; 357
Donahue ( key 20170522094913_CIT939C13) 1987; 36
Wormser ( key 20170522094913_CIT939C21) 2005; 41
Embers ( key 20170522094913_CIT939C12) 2012; 7
Li ( key 20170522094913_CIT939C30) 2011; 63
Wormser ( key 20170522094913_CIT939C2) 2006; 43
Centers for Disease Control and Prevention ( key 20170522094913_CIT939C1)
Straubinger ( key 20170522094913_CIT939C7) 2000; 38
Crowder ( key 20170522094913_CIT939C25) 2010; 5
Bockenstedt ( key 20170522094913_CIT939C9) 2002; 186
Barthold ( key 20170522094913_CIT939C11) 2010; 54
Division of AIDS, NIAID ( key 20170522094913_CIT939C20)
Klempner ( key 20170522094913_CIT939C4) 2001; 345
Krupp ( key 20170522094913_CIT939C6) 2003; 60
Wormser ( key 20170522094913_CIT939C17) 2012; 12
Wormser ( key 20170522094913_CIT939C18) 2011; 9
Hodzic ( key 20170522094913_CIT939C10) 2008; 52
Rounds ( key 20170522094913_CIT939C24) 2012; 49
24523213 - Clin Infect Dis. 2014 Apr;58(7):946-8
References_xml – volume: 47
  start-page: 89
  year: 2010
  ident: key 20170522094913_CIT939C23
  article-title: Extraction of total nucleic acids from ticks for the detection of bacterial and viral pathogens
  publication-title: J Med Entomol
  doi: 10.1093/jmedent/47.1.89
– volume: 345
  start-page: 85
  year: 2001
  ident: key 20170522094913_CIT939C4
  article-title: Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200107123450202
– volume: 49
  start-page: 843
  year: 2012
  ident: key 20170522094913_CIT939C24
  article-title: Identification of endosymbionts in ticks by broad-range polymerase chain reaction and electrospray ionization mass spectrometry
  publication-title: J Med Entomol
  doi: 10.1603/ME12038
– volume: 70
  start-page: 992
  year: 2008
  ident: key 20170522094913_CIT939C5
  article-title: A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000284604.61160.2d
– volume: 122
  start-page: 2652
  year: 2012
  ident: key 20170522094913_CIT939C28
  article-title: Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy
  publication-title: J Clin Invest
  doi: 10.1172/JCI58813
– volume: 38
  start-page: 2191
  year: 2000
  ident: key 20170522094913_CIT939C7
  article-title: PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.38.6.2191-2199.2000
– volume: 63
  start-page: 2238
  year: 2011
  ident: key 20170522094913_CIT939C30
  article-title: Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis
  publication-title: Arthritis Rheum
  doi: 10.1002/art.30384
– ident: key 20170522094913_CIT939C1
  article-title: Lyme disease
– ident: key 20170522094913_CIT939C19
  article-title: 2011 Lyme disease case definition
– volume: 293
  start-page: 421
  year: 2003
  ident: key 20170522094913_CIT939C15
  article-title: Early detection of Borrelia burgdorferi sensu lato infection in Balb/c mice by co-feeding Ixodes ricinus ticks
  publication-title: Int J Med Microbiol
  doi: 10.1078/1438-4221-00285
– volume: 181
  start-page: 1069
  year: 2000
  ident: key 20170522094913_CIT939C8
  article-title: Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: an experimental study
  publication-title: J Infect Dis
  doi: 10.1086/315340
– volume: 52
  start-page: 1728
  year: 2008
  ident: key 20170522094913_CIT939C10
  article-title: Persistence of Borrelia burgdorferi following antibiotic treatment in mice
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.01050-07
– ident: key 20170522094913_CIT939C20
  article-title: National Institutes of Health table for grading adult and pediatric adverse experiences version 1.0—December 2004 (clarification dated August 2009)
– volume: 7
  start-page: e36825
  year: 2012
  ident: key 20170522094913_CIT939C26
  article-title: Direct molecular detection and genotyping of Borrelia burgdorferi from whole blood of patients with early Lyme disease
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0036825
– volume: 357
  start-page: 1422
  year: 2007
  ident: key 20170522094913_CIT939C3
  article-title: A critical appraisal of “chronic Lyme disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra072023
– volume: 30
  start-page: 3082
  year: 1992
  ident: key 20170522094913_CIT939C29
  article-title: Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.30.12.3082-3088.1992
– volume: 12
  start-page: 535
  year: 2012
  ident: key 20170522094913_CIT939C17
  article-title: Critical analysis of treatment trials of rhesus macaques infected with Borrelia burgdorferi reveals important flaws in experimental design
  publication-title: Vector Borne Zoonotic Dis
  doi: 10.1089/vbz.2012.1012
– volume: 54
  start-page: 643
  year: 2010
  ident: key 20170522094913_CIT939C11
  article-title: Ineffectiveness of tigecycline against persistent Borrelia burgdorferi
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00788-09
– volume: 186
  start-page: 1430
  year: 2002
  ident: key 20170522094913_CIT939C9
  article-title: Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment
  publication-title: J Infect Dis
  doi: 10.1086/345284
– volume: 7
  start-page: e29914
  year: 2012
  ident: key 20170522094913_CIT939C12
  article-title: Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0029914
– volume: 22
  start-page: 387
  year: 2009
  ident: key 20170522094913_CIT939C16
  article-title: Antibiotic treatment of animals infected with Borrelia burgdorferi
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.00004-09
– volume: 48
  start-page: 472
  year: 2010
  ident: key 20170522094913_CIT939C27
  article-title: Detection and identification of Ehrlichia species in blood by use of PCR and electrospray ionization mass spectrometry
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.01669-09
– volume: 5
  start-page: e10650
  year: 2010
  ident: key 20170522094913_CIT939C25
  article-title: Genotypic variation and mixtures of Lyme Borrelia in Ixodes ticks from North America and Europe
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0010650
– volume: 60
  start-page: 1923
  year: 2003
  ident: key 20170522094913_CIT939C6
  article-title: Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000071227.23769.9E
– volume: 189
  start-page: 1515
  year: 2004
  ident: key 20170522094913_CIT939C22
  article-title: Borrelia burgdorferi infection in a natural population of Peromyscus leucopus mice: a longitudinal study in an area where Lyme borreliosis is highly endemic
  publication-title: J Infect Dis
  doi: 10.1086/382594
– volume: 43
  start-page: 1089
  year: 2006
  ident: key 20170522094913_CIT939C2
  article-title: The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America
  publication-title: Clin Infect Dis
  doi: 10.1086/508667
– volume: 27
  start-page: 1723
  year: 1989
  ident: key 20170522094913_CIT939C14
  article-title: Ear punch biopsy method for detection and isolation of Borrelia burgdorferi from rodents
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.27.8.1723-1727.1989
– volume: 41
  start-page: 958
  year: 2005
  ident: key 20170522094913_CIT939C21
  article-title: Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions
  publication-title: Clin Infect Dis
  doi: 10.1086/432935
– volume: 36
  start-page: 92
  year: 1987
  ident: key 20170522094913_CIT939C13
  article-title: Reservoir competence of white-footed mice for Lyme disease spirochetes
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.1987.36.92
– volume: 9
  start-page: 245
  year: 2011
  ident: key 20170522094913_CIT939C18
  article-title: Treatment of infection caused by Borrelia burgdorferi sensu lato
  publication-title: Expert Rev Anti Infect Ther
  doi: 10.1586/eri.10.174
– reference: 24523213 - Clin Infect Dis. 2014 Apr;58(7):946-8
SSID ssj0011805
Score 2.4416625
Snippet Background. Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various...
Animal studies suggest that Borrelia burgdorferi, the agent of Lyme disease, may persist after antibiotic therapy and can be detected by various means...
Xenodiagnosis using Ixodes scapularis larvae in humans is safe and well tolerated. There is no evidence of persistence of infection after antibiotic therapy in...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
jstor
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 937
SubjectTerms and Commentaries
Animals
Antibiotics
Arachnid Vectors - microbiology
ARTICLES AND COMMENTARIES
Bacterial diseases
Biological and medical sciences
Biopsies
Borrelia burgdorferi
Borrelia burgdorferi - genetics
Borrelia burgdorferi - isolation & purification
Borrelia infections
Erythema multiforme
Female
Glossitis, Benign Migratory - microbiology
Human bacterial diseases
Humans
Infections
Infectious diseases
Ixodes - microbiology
Lyme disease
Lyme Disease - diagnosis
Lyme Disease - transmission
Male
Medical diagnosis
Medical sciences
Medical treatment
Mice
Mice, SCID
Middle Aged
Polymerase chain reaction
Ticks
Tropical bacterial diseases
Xenodiagnosis
Xenodiagnosis - methods
Title Xenodiagnosis to Detect Borrelia burgdorferi Infection: A First-in-Human Study
URI https://www.jstor.org/stable/24031672
https://www.ncbi.nlm.nih.gov/pubmed/24523212
https://www.proquest.com/docview/1510299720
https://www.proquest.com/docview/1507791738
https://pubmed.ncbi.nlm.nih.gov/PMC3952603
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELaqISFeEAMGhTEFwQuawuIkdmLeBls1YC1ITaW-RYnjiEglRW36sn-Bf5pzrnYTqCbgJaoaK7_u8vku_u47Ql6HPAgKRX3XD2PPDQEk3Vy3DCuL0AtEKUTEdIHzeMKvZuGnOZsPBj87rKVNk7-VN3vrSv7HqvAf2FVXyf6DZe1B4Q_4DfaFLVgYtn9l47mqlwVy5apWqeFC6TWB0_e65caiyk71GkqxXJVwMYAESLuqsRh9VEHc51a1i5_xp1Zm1sgWmJJJQ9farM1qjg3Dx9lKTystvhRwv7XF-EQtDGt-mn3fsRKTDVKzp9XG_WpmTWxKhaADuFx3v0TQLoHllgrHDrh6rP14iXirDOBGLmfYscsgMos7nhd14FWgQMwfsI-SWLI1s6wagfpIfXXtyZd0NLu-TpPLedLfi7M5xH6x1tKHVPqODzmHRvmLj5_tkhSNWz6svQmjdSuCMzjxGZ62F90gwVWzbbM12KvETin7UpnfGbmdECd5QO5vcxPnHB3tkAxU_ZDcHW_ZF4_IpOdvTrN00N8c429Ox98c62_vnHOn721O622PyWx0mXy4crf9OFwZsrhxcxVypZe5dVqRSRZ7YVawEnJsj0nKRUFpkIW6cjkqlSd9iF4LGRd-DCl_qePGI3JQL2v1lDiSM1XCZKK4kGHpi5xJLoOcRxAQZxGjQ_LGPMdUbsXqdc-URYqkiSDVHafxmQ_JKzv2B0q07B111JrDDtFClJRH_pCc9OyzGwDJCYUJbUiOjcHS7cu_TiFQ9nxddO4NyUu7G6BZr7dltYKXMtW5ViRoFMAhnqB9O2dnkMtQOHvUs7wdoGXf-3vq6lsr_x4I5nMveHb7ZT0n93bv6DE5aFYb9QLi5yY_af36F7WAyJg
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Xenodiagnosis+to+Detect+Borrelia+burgdorferi+Infection%3A+A+First-in-Human+Study&rft.jtitle=Clinical+infectious+diseases&rft.au=Marques%2C+Adriana&rft.au=Telford%2C+Sam+R&rft.au=Turk%2C+Siu-Ping&rft.au=Chung%2C+Erin&rft.date=2014-04-01&rft.pub=Oxford+University+Press&rft.issn=1058-4838&rft.eissn=1537-6591&rft.volume=58&rft.issue=7&rft.spage=937&rft_id=info:doi/10.1093%2Fcid%2Fcit939&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3256864721
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1058-4838&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1058-4838&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1058-4838&client=summon